Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 3
1976 2
1977 7
1978 12
1979 4
1980 4
1981 7
1982 18
1983 14
1984 14
1985 13
1986 12
1987 13
1988 25
1989 20
1990 20
1991 35
1992 34
1993 18
1994 20
1995 13
1996 20
1997 12
1998 17
1999 16
2000 33
2001 27
2002 30
2003 30
2004 22
2005 27
2006 25
2007 23
2008 22
2009 17
2010 14
2011 20
2012 20
2013 15
2014 17
2015 15
2016 15
2017 16
2018 21
2019 16
2020 28
2021 23
2022 17
2023 15
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

834 results

Results by year

Filters applied: . Clear all
Page 1
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, Lee Y, Lui LMW, Mansur RB, Papakostas GI, Subramaniapillai M, Thase M, Vieta E, Young AH, Zarate CA Jr, Stahl S. McIntyre RS, et al. Among authors: nemeroff cb. Am J Psychiatry. 2021 May 1;178(5):383-399. doi: 10.1176/appi.ajp.2020.20081251. Epub 2021 Mar 17. Am J Psychiatry. 2021. PMID: 33726522 Free PMC article. Review.
Psychedelics and Psychedelic-Assisted Psychotherapy.
Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM; the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Reiff CM, et al. Among authors: nemeroff cb. Am J Psychiatry. 2020 May 1;177(5):391-410. doi: 10.1176/appi.ajp.2019.19010035. Epub 2020 Feb 26. Am J Psychiatry. 2020. PMID: 32098487 Review.
Neuroimaging Biomarkers in Schizophrenia.
Kraguljac NV, McDonald WM, Widge AS, Rodriguez CI, Tohen M, Nemeroff CB. Kraguljac NV, et al. Among authors: nemeroff cb. Am J Psychiatry. 2021 Jun;178(6):509-521. doi: 10.1176/appi.ajp.2020.20030340. Epub 2021 Jan 5. Am J Psychiatry. 2021. PMID: 33397140 Free PMC article. Review.
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB; American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments. Sanacora G, et al. Among authors: nemeroff cb. JAMA Psychiatry. 2017 Apr 1;74(4):399-405. doi: 10.1001/jamapsychiatry.2017.0080. JAMA Psychiatry. 2017. PMID: 28249076 Review.
Hormonal Treatments for Major Depressive Disorder: State of the Art.
Dwyer JB, Aftab A, Radhakrishnan R, Widge A, Rodriguez CI, Carpenter LL, Nemeroff CB, McDonald WM, Kalin NH; APA Council of Research Task Force on Novel Biomarkers and Treatments. Dwyer JB, et al. Among authors: nemeroff cb. Am J Psychiatry. 2020 Aug 1;177(8):686-705. doi: 10.1176/appi.ajp.2020.19080848. Epub 2020 May 27. Am J Psychiatry. 2020. PMID: 32456504 Free PMC article. Review.
In Search of Biomarkers to Guide Interventions in Autism Spectrum Disorder: A Systematic Review.
Parellada M, Andreu-Bernabeu Á, Burdeus M, San José Cáceres A, Urbiola E, Carpenter LL, Kraguljac NV, McDonald WM, Nemeroff CB, Rodriguez CI, Widge AS, State MW, Sanders SJ. Parellada M, et al. Among authors: nemeroff cb. Am J Psychiatry. 2023 Jan 1;180(1):23-40. doi: 10.1176/appi.ajp.21100992. Epub 2022 Dec 7. Am J Psychiatry. 2023. PMID: 36475375 Free PMC article. Review.
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.
Sforzini L, Worrell C, Kose M, Anderson IM, Aouizerate B, Arolt V, Bauer M, Baune BT, Blier P, Cleare AJ, Cowen PJ, Dinan TG, Fagiolini A, Ferrier IN, Hegerl U, Krystal AD, Leboyer M, McAllister-Williams RH, McIntyre RS, Meyer-Lindenberg A, Miller AH, Nemeroff CB, Normann C, Nutt D, Pallanti S, Pani L, Penninx BWJH, Schatzberg AF, Shelton RC, Yatham LN, Young AH, Zahn R, Aislaitner G, Butlen-Ducuing F, Fletcher C, Haberkamp M, Laughren T, Mäntylä FL, Schruers K, Thomson A, Arteaga-Henríquez G, Benedetti F, Cash-Gibson L, Chae WR, De Smedt H, Gold SM, Hoogendijk WJG, Mondragón VJ, Maron E, Martynowicz J, Melloni E, Otte C, Perez-Fuentes G, Poletti S, Schmidt ME, van de Ketterij E, Woo K, Flossbach Y, Ramos-Quiroga JA, Savitz AJ, Pariante CM. Sforzini L, et al. Among authors: nemeroff cb. Mol Psychiatry. 2022 Mar;27(3):1286-1299. doi: 10.1038/s41380-021-01381-x. Epub 2021 Dec 15. Mol Psychiatry. 2022. PMID: 34907394 Free PMC article. Review.
Risks and Benefits of Cannabis and Cannabinoids in Psychiatry.
Hill KP, Gold MS, Nemeroff CB, McDonald W, Grzenda A, Widge AS, Rodriguez C, Kraguljac NV, Krystal JH, Carpenter LL. Hill KP, et al. Among authors: nemeroff cb. Am J Psychiatry. 2022 Feb;179(2):98-109. doi: 10.1176/appi.ajp.2021.21030320. Epub 2021 Dec 8. Am J Psychiatry. 2022. PMID: 34875873 Review.
834 results